ARTICLE | Clinical News
Single-agent ribavirin regulatory update
April 7, 2014 7:00 AM UTC
Pharmascience's Pendopharm division said Health Canada granted Priority Review to an application for single-agent ribavirin to treat HCV infection. Pendopharm said that ribavirin is available only in ...